nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Pigmentation disorder—Sunitinib—kidney cancer	0.0504	0.0504	CcSEcCtD
Molindone—Pigmentation disorder—Paclitaxel—kidney cancer	0.0338	0.0338	CcSEcCtD
Molindone—Pigmentation disorder—Capecitabine—kidney cancer	0.0278	0.0278	CcSEcCtD
Molindone—Amenorrhoea—Everolimus—kidney cancer	0.0229	0.0229	CcSEcCtD
Molindone—Leukocytosis—Everolimus—kidney cancer	0.0214	0.0214	CcSEcCtD
Molindone—Pigmentation disorder—Doxorubicin—kidney cancer	0.0179	0.0179	CcSEcCtD
Molindone—Dysphagia—Temsirolimus—kidney cancer	0.017	0.017	CcSEcCtD
Molindone—Gynaecomastia—Sorafenib—kidney cancer	0.0156	0.0156	CcSEcCtD
Molindone—Weight decreased—Temsirolimus—kidney cancer	0.0154	0.0154	CcSEcCtD
Molindone—Weight decreased—Pazopanib—kidney cancer	0.0145	0.0145	CcSEcCtD
Molindone—Urinary retention—Everolimus—kidney cancer	0.0139	0.0139	CcSEcCtD
Molindone—Dysphagia—Everolimus—kidney cancer	0.0126	0.0126	CcSEcCtD
Molindone—Dysphagia—Erlotinib—kidney cancer	0.0122	0.0122	CcSEcCtD
Molindone—Dyskinesia—Paclitaxel—kidney cancer	0.012	0.012	CcSEcCtD
Molindone—Weight decreased—Everolimus—kidney cancer	0.0114	0.0114	CcSEcCtD
Molindone—Weight decreased—Erlotinib—kidney cancer	0.011	0.011	CcSEcCtD
Molindone—Dysphagia—Sorafenib—kidney cancer	0.011	0.011	CcSEcCtD
Molindone—Muscle spasms—Pazopanib—kidney cancer	0.0107	0.0107	CcSEcCtD
Molindone—Leukopenia—Temsirolimus—kidney cancer	0.0106	0.0106	CcSEcCtD
Molindone—Dysphagia—Sunitinib—kidney cancer	0.0106	0.0106	CcSEcCtD
Molindone—Vision blurred—Pazopanib—kidney cancer	0.0105	0.0105	CcSEcCtD
Molindone—Dysphagia—Dactinomycin—kidney cancer	0.00999	0.00999	CcSEcCtD
Molindone—Leukopenia—Pazopanib—kidney cancer	0.00998	0.00998	CcSEcCtD
Molindone—Weight decreased—Sorafenib—kidney cancer	0.00992	0.00992	CcSEcCtD
Molindone—Urinary retention—Vincristine—kidney cancer	0.00982	0.00982	CcSEcCtD
Molindone—Weight decreased—Sunitinib—kidney cancer	0.00955	0.00955	CcSEcCtD
Molindone—Dry mouth—Pazopanib—kidney cancer	0.00928	0.00928	CcSEcCtD
Molindone—Dyspnoea—Temsirolimus—kidney cancer	0.00861	0.00861	CcSEcCtD
Molindone—Somnolence—Temsirolimus—kidney cancer	0.00859	0.00859	CcSEcCtD
Molindone—Muscle spasms—Everolimus—kidney cancer	0.00846	0.00846	CcSEcCtD
Molindone—Vision blurred—Everolimus—kidney cancer	0.0083	0.0083	CcSEcCtD
Molindone—Constipation—Temsirolimus—kidney cancer	0.00826	0.00826	CcSEcCtD
Molindone—Tremor—Everolimus—kidney cancer	0.00825	0.00825	CcSEcCtD
Molindone—Dyspnoea—Pazopanib—kidney cancer	0.00811	0.00811	CcSEcCtD
Molindone—Agitation—Everolimus—kidney cancer	0.00809	0.00809	CcSEcCtD
Molindone—Somnolence—Pazopanib—kidney cancer	0.00809	0.00809	CcSEcCtD
Molindone—Weight decreased—Vincristine—kidney cancer	0.00807	0.00807	CcSEcCtD
Molindone—Leukopenia—Vinblastine—kidney cancer	0.00791	0.00791	CcSEcCtD
Molindone—Leukopenia—Everolimus—kidney cancer	0.00788	0.00788	CcSEcCtD
Molindone—Muscle spasms—Sorafenib—kidney cancer	0.00735	0.00735	CcSEcCtD
Molindone—Dry mouth—Everolimus—kidney cancer	0.00733	0.00733	CcSEcCtD
Molindone—Dysphagia—Paclitaxel—kidney cancer	0.00709	0.00709	CcSEcCtD
Molindone—Muscle spasms—Sunitinib—kidney cancer	0.00707	0.00707	CcSEcCtD
Molindone—Tachycardia—Everolimus—kidney cancer	0.00701	0.00701	CcSEcCtD
Molindone—Leukopenia—Sorafenib—kidney cancer	0.00684	0.00684	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—kidney cancer	0.0068	0.0068	CcSEcCtD
Molindone—Hypotension—Everolimus—kidney cancer	0.00671	0.00671	CcSEcCtD
Molindone—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.00668	0.00668	CcSEcCtD
Molindone—Leukopenia—Sunitinib—kidney cancer	0.00658	0.00658	CcSEcCtD
Molindone—Weight increased—Paclitaxel—kidney cancer	0.00645	0.00645	CcSEcCtD
Molindone—Weight decreased—Paclitaxel—kidney cancer	0.00641	0.00641	CcSEcCtD
Molindone—Dyspnoea—Everolimus—kidney cancer	0.0064	0.0064	CcSEcCtD
Molindone—Urinary retention—Capecitabine—kidney cancer	0.0064	0.0064	CcSEcCtD
Molindone—Somnolence—Everolimus—kidney cancer	0.00639	0.00639	CcSEcCtD
Molindone—Dry mouth—Sorafenib—kidney cancer	0.00636	0.00636	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—kidney cancer	0.00636	0.00636	CcSEcCtD
Molindone—Leukopenia—Dactinomycin—kidney cancer	0.00623	0.00623	CcSEcCtD
Molindone—Dyspnoea—Erlotinib—kidney cancer	0.00618	0.00618	CcSEcCtD
Molindone—Constipation—Vinblastine—kidney cancer	0.00617	0.00617	CcSEcCtD
Molindone—Constipation—Everolimus—kidney cancer	0.00614	0.00614	CcSEcCtD
Molindone—Dry mouth—Sunitinib—kidney cancer	0.00612	0.00612	CcSEcCtD
Molindone—Rash—Temsirolimus—kidney cancer	0.00609	0.00609	CcSEcCtD
Molindone—Dermatitis—Temsirolimus—kidney cancer	0.00608	0.00608	CcSEcCtD
Molindone—Constipation—Erlotinib—kidney cancer	0.00593	0.00593	CcSEcCtD
Molindone—Dysphagia—Capecitabine—kidney cancer	0.00582	0.00582	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—kidney cancer	0.0058	0.0058	CcSEcCtD
Molindone—Rash—Pazopanib—kidney cancer	0.00574	0.00574	CcSEcCtD
Molindone—Nausea—Temsirolimus—kidney cancer	0.00574	0.00574	CcSEcCtD
Molindone—Dermatitis—Pazopanib—kidney cancer	0.00573	0.00573	CcSEcCtD
Molindone—Agitation—Vincristine—kidney cancer	0.00571	0.00571	CcSEcCtD
Molindone—Leukopenia—Vincristine—kidney cancer	0.00557	0.00557	CcSEcCtD
Molindone—Dyspnoea—Sorafenib—kidney cancer	0.00556	0.00556	CcSEcCtD
Molindone—Nausea—Pazopanib—kidney cancer	0.0054	0.0054	CcSEcCtD
Molindone—Dyspnoea—Sunitinib—kidney cancer	0.00535	0.00535	CcSEcCtD
Molindone—Constipation—Sorafenib—kidney cancer	0.00533	0.00533	CcSEcCtD
Molindone—Weight increased—Capecitabine—kidney cancer	0.00529	0.00529	CcSEcCtD
Molindone—Leukopenia—Gemcitabine—kidney cancer	0.00528	0.00528	CcSEcCtD
Molindone—Weight decreased—Capecitabine—kidney cancer	0.00526	0.00526	CcSEcCtD
Molindone—Constipation—Sunitinib—kidney cancer	0.00513	0.00513	CcSEcCtD
Molindone—Muscle spasms—Paclitaxel—kidney cancer	0.00475	0.00475	CcSEcCtD
Molindone—Hypotension—Vincristine—kidney cancer	0.00474	0.00474	CcSEcCtD
Molindone—Vision blurred—Paclitaxel—kidney cancer	0.00465	0.00465	CcSEcCtD
Molindone—Tremor—Paclitaxel—kidney cancer	0.00463	0.00463	CcSEcCtD
Molindone—Agitation—Paclitaxel—kidney cancer	0.00454	0.00454	CcSEcCtD
Molindone—Rash—Everolimus—kidney cancer	0.00453	0.00453	CcSEcCtD
Molindone—Dermatitis—Everolimus—kidney cancer	0.00453	0.00453	CcSEcCtD
Molindone—Hypotension—Gemcitabine—kidney cancer	0.0045	0.0045	CcSEcCtD
Molindone—Leukopenia—Paclitaxel—kidney cancer	0.00442	0.00442	CcSEcCtD
Molindone—Rash—Erlotinib—kidney cancer	0.00437	0.00437	CcSEcCtD
Molindone—Dermatitis—Erlotinib—kidney cancer	0.00437	0.00437	CcSEcCtD
Molindone—Constipation—Vincristine—kidney cancer	0.00434	0.00434	CcSEcCtD
Molindone—Dyspnoea—Gemcitabine—kidney cancer	0.00429	0.00429	CcSEcCtD
Molindone—Nausea—Vinblastine—kidney cancer	0.00428	0.00428	CcSEcCtD
Molindone—Somnolence—Gemcitabine—kidney cancer	0.00428	0.00428	CcSEcCtD
Molindone—Nausea—Everolimus—kidney cancer	0.00427	0.00427	CcSEcCtD
Molindone—Constipation—Gemcitabine—kidney cancer	0.00412	0.00412	CcSEcCtD
Molindone—Nausea—Erlotinib—kidney cancer	0.00412	0.00412	CcSEcCtD
Molindone—Dry mouth—Paclitaxel—kidney cancer	0.00411	0.00411	CcSEcCtD
Molindone—Tachycardia—Paclitaxel—kidney cancer	0.00393	0.00393	CcSEcCtD
Molindone—Rash—Sorafenib—kidney cancer	0.00393	0.00393	CcSEcCtD
Molindone—Dermatitis—Sorafenib—kidney cancer	0.00393	0.00393	CcSEcCtD
Molindone—Muscle spasms—Capecitabine—kidney cancer	0.0039	0.0039	CcSEcCtD
Molindone—Vision blurred—Capecitabine—kidney cancer	0.00382	0.00382	CcSEcCtD
Molindone—Tremor—Capecitabine—kidney cancer	0.0038	0.0038	CcSEcCtD
Molindone—Rash—Sunitinib—kidney cancer	0.00378	0.00378	CcSEcCtD
Molindone—Dermatitis—Sunitinib—kidney cancer	0.00378	0.00378	CcSEcCtD
Molindone—Hypotension—Paclitaxel—kidney cancer	0.00377	0.00377	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—kidney cancer	0.00375	0.00375	CcSEcCtD
Molindone—Nausea—Sorafenib—kidney cancer	0.0037	0.0037	CcSEcCtD
Molindone—Leukopenia—Capecitabine—kidney cancer	0.00363	0.00363	CcSEcCtD
Molindone—Dyspnoea—Paclitaxel—kidney cancer	0.00359	0.00359	CcSEcCtD
Molindone—Somnolence—Paclitaxel—kidney cancer	0.00358	0.00358	CcSEcCtD
Molindone—Rash—Dactinomycin—kidney cancer	0.00358	0.00358	CcSEcCtD
Molindone—Nausea—Sunitinib—kidney cancer	0.00356	0.00356	CcSEcCtD
Molindone—Constipation—Paclitaxel—kidney cancer	0.00345	0.00345	CcSEcCtD
Molindone—Weight increased—Doxorubicin—kidney cancer	0.00341	0.00341	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—kidney cancer	0.00339	0.00339	CcSEcCtD
Molindone—Dry mouth—Capecitabine—kidney cancer	0.00337	0.00337	CcSEcCtD
Molindone—Nausea—Dactinomycin—kidney cancer	0.00337	0.00337	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—kidney cancer	0.00334	0.00334	CcSEcCtD
Molindone—Tachycardia—Capecitabine—kidney cancer	0.00323	0.00323	CcSEcCtD
Molindone—Rash—Vincristine—kidney cancer	0.0032	0.0032	CcSEcCtD
Molindone—Dermatitis—Vincristine—kidney cancer	0.0032	0.0032	CcSEcCtD
Molindone—Hypotension—Capecitabine—kidney cancer	0.00309	0.00309	CcSEcCtD
Molindone—Rash—Gemcitabine—kidney cancer	0.00304	0.00304	CcSEcCtD
Molindone—Dermatitis—Gemcitabine—kidney cancer	0.00303	0.00303	CcSEcCtD
Molindone—Nausea—Vincristine—kidney cancer	0.00301	0.00301	CcSEcCtD
Molindone—Dyspnoea—Capecitabine—kidney cancer	0.00295	0.00295	CcSEcCtD
Molindone—Nausea—Gemcitabine—kidney cancer	0.00286	0.00286	CcSEcCtD
Molindone—Constipation—Capecitabine—kidney cancer	0.00283	0.00283	CcSEcCtD
Molindone—Rash—Paclitaxel—kidney cancer	0.00254	0.00254	CcSEcCtD
Molindone—Dermatitis—Paclitaxel—kidney cancer	0.00254	0.00254	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—kidney cancer	0.00251	0.00251	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—kidney cancer	0.00246	0.00246	CcSEcCtD
Molindone—Agitation—Doxorubicin—kidney cancer	0.0024	0.0024	CcSEcCtD
Molindone—Nausea—Paclitaxel—kidney cancer	0.00239	0.00239	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—kidney cancer	0.00234	0.00234	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—kidney cancer	0.00218	0.00218	CcSEcCtD
Molindone—Rash—Capecitabine—kidney cancer	0.00209	0.00209	CcSEcCtD
Molindone—Dermatitis—Capecitabine—kidney cancer	0.00208	0.00208	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—kidney cancer	0.00208	0.00208	CcSEcCtD
Molindone—Hypotension—Doxorubicin—kidney cancer	0.00199	0.00199	CcSEcCtD
Molindone—Nausea—Capecitabine—kidney cancer	0.00196	0.00196	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—kidney cancer	0.0019	0.0019	CcSEcCtD
Molindone—Somnolence—Doxorubicin—kidney cancer	0.0019	0.0019	CcSEcCtD
Molindone—Constipation—Doxorubicin—kidney cancer	0.00182	0.00182	CcSEcCtD
Molindone—Rash—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Molindone—Nausea—Doxorubicin—kidney cancer	0.00127	0.00127	CcSEcCtD
